教育レベルがアルコール使用と不全性心疾患の死亡率との関係を変化させるのか? イギリスのバイオバンクからの証拠

Tara Martin¹, Laura Llamosas-Falcón², Yachen Zhu³

¹Institute for Mental Health Policy Research, Centre for Addiction and Mental Health (CAMH), 250 College Street, Toronto, ON, M5T 1R8, Canada; Dalla Lana School of Public Health, University of Toronto, 155 College Street, M5T 1P8, Toronto, ON, Canada.

Nutrition, metabolism, and cardiovascular diseases : NMCD

|February 18, 2026

まとめ

アルコール摂取と心不全性疾患 (IHD) 死亡リスクは,英国の男性における教育レベルによって異なります. 教育レベルが低い場合,アルコールに対する脆弱性が高まる可能性があります.

科学分野:

心血管伝染病学心血管伝染病学
公衆衛生研究公共衛生研究
健康の社会経済的決定要因

背景:

アルコール摂取は,心不全性疾患 (IHD) 死亡率と関連しています.
社会経済的地位 (SES) は,IHDの負担とアルコールの健康への影響に影響を与えます.
学歴はSESの重要な指標である.

研究の目的:

英国におけるアルコールの使用とIHDの死亡率との関連を教育レベルがどのように変化させるかを調査する.
この関係における性別の違いを探求するために.

主な方法:

現在飲酒している387,914人の (40-69歳) UK Biobankのデータを用いたコホート研究.
IHDの死亡率は,国家死亡記録を通じて特定されました.
コックス比例リスクモデルは,アルコールの使用,教育,IHDの死亡リスクを分析した.

主要な成果:

低教育は,より高いIHD死亡リスクと関連していました.
男性では,適度なアルコール使用 (>1〜30g/日) は,偶発的な飲酒と比較して39%低いIHD死亡リスクを示しました.
アルコールの使用とIHDの死亡率との間の教育による異なる関連性は,男性では観察されたが,女性では観察されなかった.

結論:

アルコール使用とIHDの死亡リスクとの関係は,男性の教育レベルに影響されます.
IHDの死亡率に対するアルコール使用の性および教育特有のリスクを理解するために,さらなる研究が必要です.

キーワード:

さらに関連する動画

05:40

The Motivation for Alcohol Reward: Predictors of Progressive-Ratio Intravenous Alcohol Self-Administration in Humans

Published on: April 28, 2022

3.2K

関連する概念動画

01:16

Hypothesis Test for Test of Independence

8.3K

The test of independence is a chi-square-based test used to determine whether two variables or factors are independent or dependent. This hypothesis test is used to examine the independence of the variables. One can construct two qualitative survey questions or experiments based on the variables in a contingency table. The goal is to see if the two variables are unrelated (independent) or related (dependent). The null and alternative hypotheses for this test are:
H0: The two variables (factors)...

8.3K

01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

291

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...

291

01:29

Bias in Epidemiological Studies

1.4K

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:

1.4K

01:30

Coronary Artery Disease I: Introduction

1.2K

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...

1.2K

01:26

Coronary Artery Disease IV: Preventive Measures

741

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...

741

01:26

Atherosclerosis III: Management

465

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

465

関連する実験動画